CytoDyn Inc. (CYDY)
OTCMKTS · Delayed Price · Currency is USD
0.230415
-0.004985 (-2.12%)
At close: Jul 7, 2026
CytoDyn Market Cap
CytoDyn has a market cap or net worth of $316.43 million as of July 7, 2026. Its market cap has decreased by -18.27% in one year.
Market Cap
316.43M
Enterprise Value
329.60M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.23
Market Cap Chart
Since November 17, 2005, CytoDyn's market cap has increased from 5.54M to 316.43M, an increase of 5,614.32%. That is a compound annual growth rate of 21.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 7, 2026 | 316.43M | -11.02% |
| Dec 31, 2025 | 355.63M | 164.14% |
| Dec 31, 2024 | 134.63M | -29.42% |
| Dec 29, 2023 | 190.74M | 2.63% |
| Dec 30, 2022 | 185.85M | -72.64% |
| Dec 31, 2021 | 679.28M | -78.86% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Silence Therapeutics | 499.74M |
| Glorywin Entertainment Group | 359.76M |
| Northwest Biotherapeutics | 311.46M |
| Vaxart | 148.88M |
| HST Global | 99.00M |
| NDT Pharmaceuticals | 87.78M |
| BioStem Technologies | 64.88M |
| Cell Source | 59.42M |